Ethan J Mueller

Ethan Mueller supports the National Heart, Lung, and Blood Institute (NHLBI) in executing mission-critical procurement activities aligned with its mandate to advance biomedical research in cardiovascular, pulmonary, hematologic, and sleep disorders. Though his official title is not publicly designated, he plays a central role in managing acquisitions for high-complexity analytical laboratory instrumentation, research services, and biologic data infrastructure. His work directly enables cutting-edge scientific discovery, particularly in precision medicine and single-cell genomics, by ensuring timely access to state-of-the-art equipment and specialized technical services essential for NIH-funded research initiatives. Mueller maintains consistent procurement relationships with a select group of institutional and technical partners, including the University of Mississippi Medical Center, Wake Forest University Health Sciences, and TDA Research, Inc. These entities provide specialized research services, clinical laboratory capabilities, and advanced instrumentation development. His contracting patterns reflect a preference for established academic medical centers and mid-sized technology firms with proven expertise in life sciences R&D, indicating a focus on long-term, high-reliability vendor partnerships rather than transactional procurement. Mueller’s portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and scientific rigor over socioeconomic categorization, prioritizing the most qualified providers regardless of business size or certification status. While small business participation is not formally incentivized in his portfolio, vendor selection remains driven by domain expertise and demonstrated capacity to meet NHLBI’s rigorous scientific requirements. His procurement focus is overwhelmingly centered on NAICS 334516 (Analytical Laboratory Instrument Manufacturing), with significant activity also in NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and NAICS 621511 (Medical Laboratories). He routinely procures next-generation sequencing platforms, mass spectrometers, flow cytometers, and bioinformatics infrastructure, demonstrating deep technical fluency in molecular diagnostics and translational research tools.